Literature DB >> 2782974

Correlation between synovial neopterin and inflammatory activity in rheumatoid arthritis.

A Krause1, H Protz, K M Goebel.   

Abstract

According to recent investigations neopterin (a pyrazinopyrimidine derivative) is a biochemical marker that reflects the activity of the proinflammatory immunocellular system of the synovial tissue in rheumatoid arthritis (RA). Interferon gamma, derived from antigen activated T lymphocytes, stimulates macrophages to synthesise and release neopterin into the culture supernatant in vitro. To extend this in vitro model to a clinical level a sensitive new radioimmunoassay technique was used to measure neopterin concentrations in the synovial fluid (SF) of 17 patients with active RA, nine with osteoarthritis, and six with acute gout, and in that of 12 controls undergoing meniscectomy. The SF neopterin concentrations were significantly higher in patients with RA than in the other groups of patients, particularly the controls. Multivariant analysis showed that SF neopterin concentrations correspond better with the systemic inflammatory activity of RA than with the local disease activity of the knee joints. Thus the study strengthens the hypothesis that neopterin reflects the essential role of the activated immunocellular reaction in the pathogenesis of RA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2782974      PMCID: PMC1003838          DOI: 10.1136/ard.48.8.636

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  22 in total

1.  Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Authors:  A Larsen; K Dale; M Eek
Journal:  Acta Radiol Diagn (Stockh)       Date:  1977-07

2.  Assessment of rheumatoid activity based on clinical features and blood and synovial fluid analysis.

Authors:  M Farr; M J Kendall; D W Young; M J Meynell; C F Hawkins
Journal:  Ann Rheum Dis       Date:  1976-04       Impact factor: 19.103

3.  Biopterin derivatives in human body fluids and tissues.

Authors:  R J Leeming; J A Blair; V Melikian; D J O'Gorman
Journal:  J Clin Pathol       Date:  1976-05       Impact factor: 3.411

4.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

5.  Protease inhibitors in inflammatory synovial effusions.

Authors:  N M Hadler; A M Johnson; J K Spitznagel; R J Quinet
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

6.  Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants.

Authors:  C Huber; D Fuchs; A Hausen; R Margreiter; G Reibnegger; M Spielberger; H Wachter
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

7.  Isolation of an interleukin-1-like factor from human joint effusions.

Authors:  D D Wood; E J Ihrie; C A Dinarello; P L Cohen
Journal:  Arthritis Rheum       Date:  1983-08

8.  Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells.

Authors:  J M Dayer; J Bréard; L Chess; S M Krane
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

9.  Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation.

Authors:  G Janossy; G Panayi; O Duke; M Bofill; L W Poulter; G Goldstein
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

10.  Change of prostaglandin E level in joint fluids after treatment with flurbiprofen in patients with rheumatoid arthritis and osteoarthritis.

Authors:  M Tokunaga; K Ohuchi; S Yoshizawa; S Tsurufuji; A Rikimaru; E Wakamatsu
Journal:  Ann Rheum Dis       Date:  1981-10       Impact factor: 19.103

View more
  2 in total

1.  Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.

Authors:  G Hahn; B Stuhlmüller; N Hain; J R Kalden; K Pfizenmaier; G R Burmester
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

2.  The early diagnostic value of serum neopterin and cartilage oligomeric matrix protein for osteoarticular changes among brucellosis patients at an early period.

Authors:  Zhi-Jun Zhao; Qiang Li; Li Ma; Ji-Quan Li; Li-Qing Xu
Journal:  J Orthop Surg Res       Date:  2018-09-04       Impact factor: 2.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.